Post-Stroke Enhancement of Delirium Outcomes With Reduction in Neuro-checks
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Sep 12, 2023
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how overnight neuro-checks, which are regular checks on a patient's brain function, might affect the risk of delirium in patients who have had an acute stroke. Delirium is a sudden change in mental status that can cause confusion and disorientation. The researchers want to find out if allowing patients to get better sleep by stopping these checks at night could help reduce delirium and improve overall recovery.
To participate in this study, individuals must be at least 18 years old and admitted to the hospital with an acute stroke. They will be evaluated by healthcare professionals to ensure their medical condition is stable enough to stop the overnight checks. This trial is not yet recruiting participants, but it is open to all genders. If you or a loved one is considering joining this study, you can expect a focus on how modifying these nighttime checks may lead to better health outcomes after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Admitted with acute stroke Age greater or equal to 18 years old Medical and neurologic stability for discontinuation of neuro-checks, determined by the Stroke Service NP and Attending Physician (no uncontrolled fluctuation in vital signs, seizure like activity or worsening neurologic function) Ability to give informed consent, or identifiable surrogate decision maker
- Exclusion Criteria:
- • Surgical hemorrhagic stroke Subarachnoid hemorrhage Medical or neurologic instability Pregnancy Inmates
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported